ACCC Seeking Opinion from Participants Related to Elanco’s Proposed Divestment

  • May 29, 2020 AEST
  • Team Kalkine

ACCC is seeking opinions on a divestment undertaking offered by Elanco pertaining to its proposed acquisition of Bayer Aktiengesellschaft’s animal health business.

The ACCC has initial competition concerns related to worming treatments frequently used for cats & dogs, as the acquisition would merge ownership of Elanco’s Milbemax and, Interceptor brands with Bayer’s Drontal, Profender and Droncit brands.

Other preliminary concern was related to the consolidation in sheep lice products.

The proposed divestment task would compel Elanco to sell the Drontal, Profender and Droncit worming brands, and the Avenge+Fly sheep lice brand to a buyer or buyers authorized by the ACCC.

The ACCC now seeks opinions from market participants on whether the planned undertaking would be likely to alleviate competition worries in sheep lice therapies, and intestinal worming treatments for companion animals.


The website is a service of Kalkine Media Pty. Ltd. A.C.N. 629 651 672. The article has been prepared for informational purposes only and is not intended to be used as a complete source of information on any particular company. Kalkine Media does not in any way endorse or recommend individuals, products or services that may be discussed on this site. Our publications are NOT a solicitation or recommendation to buy, sell or hold the stock of the company (or companies) or engage in any investment activity under discussion. We are neither licensed nor qualified to provide investment advice through this platform. All pictures are copyright to their respective owner(s). does not claim ownership of any of the pictures displayed on this website unless stated otherwise. Some of the images used on this website are taken from the web and are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it below the image.


There is no investor left unperturbed with the ongoing trade conflicts between US-China and the devastating bushfire in Australia.

Are you wondering if the year 2020 might not have taken the right start? Dividend stocks could be the answer to that question.

As interest rates in Australia are already at record low levels, find out which dividend stocks are viewed as the most attractive investment opportunity in the current scenario in our report.

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it. OK